藥 物 回 收
|
| |
| Singapore: Recall of Bilaxten (bilastine) Tablet 20mg (English only) |
| |
Health Sciences Authority (HSA) announces that A. Menarini Singapore Pte. Ltd. is recalling one batch of Bilaxten Tablet 20mg (bilastine) (batch number: 2536B) to the retail level because some blister strips in the affected batch were found without printed product information.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-bilaxten-(bilastine)-tablet-20mg
In Hong Kong, Labixten Tablets 20mg (HK-63485) is a pharmaceutical product containing bilastine which is registered by A. Menarini Hong Kong Limited (A. Menarini). The product is a prescription-only medicine. As confirmed with A. Menarini, the affected batch has not been imported into Hong Kong.
Ends/Thursday, Jan 4, 2024
Issued at HKT 14:30
|
| |
